Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy ; volume:43 ; number:1 ; day:21 ; month:8 ; year:2024 ; pages:1-9 ; date:12.2024
Journal of experimental & clinical cancer research ; 43, Heft 1 (21.8.2024), 1-9, 12.2024

Creator: Chan, Wei Yen
Lee, Jenny H.
Stewart, Ashleigh
Diefenbach, Russell J.
Gonzalez, Maria
Menzies, Alexander M.
Blank, Christian
Scolyer, Richard A.
Long, Georgina V.
Rizos, Helen

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13046-024-03153-1

URN: urn:nbn:de:101:1-2411072101579.292948396317

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:32 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Chan, Wei Yen
Lee, Jenny H.
Stewart, Ashleigh
Diefenbach, Russell J.
Gonzalez, Maria
Menzies, Alexander M.
Blank, Christian
Scolyer, Richard A.
Long, Georgina V.
Rizos, Helen
SpringerLink (Online service)

Other Objects (12)

Radiotherapy for patients with locally advanced esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy

Imaging of tumour response to immunotherapy

Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma

Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy

HNSCC: tumour antigens and their targeting by immunotherapy

Postoperative recurrence in locally advanced rectal cancer: how does neoadjuvant treatment affect recurrence pattern?

Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge—December 1st–2nd, 2021

The tumour microenvironment, treatment resistance and recurrence in glioblastoma

Infectious morbidity in pediatric patients receiving neoadjuvant chemotherapy for sarcoma

Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs

Does immunotherapy reduce the recurrence rate in nasal polyposis?

Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC

Radiotherapy for patients with locally advanced esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy

Imaging of tumour response to immunotherapy

Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma

Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy

HNSCC: tumour antigens and their targeting by immunotherapy

Postoperative recurrence in locally advanced rectal cancer: how does neoadjuvant treatment affect recurrence pattern?

Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge—December 1st–2nd, 2021

The tumour microenvironment, treatment resistance and recurrence in glioblastoma

Infectious morbidity in pediatric patients receiving neoadjuvant chemotherapy for sarcoma

Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs

Does immunotherapy reduce the recurrence rate in nasal polyposis?

Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC

Radiotherapy for patients with locally advanced esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy

Imaging of tumour response to immunotherapy

Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma

Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy

HNSCC: tumour antigens and their targeting by immunotherapy

Postoperative recurrence in locally advanced rectal cancer: how does neoadjuvant treatment affect recurrence pattern?

Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge—December 1st–2nd, 2021

The tumour microenvironment, treatment resistance and recurrence in glioblastoma

Infectious morbidity in pediatric patients receiving neoadjuvant chemotherapy for sarcoma

Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs

Does immunotherapy reduce the recurrence rate in nasal polyposis?

Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Radiotherapy for patients with locally advanced esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy

Imaging of tumour response to immunotherapy

Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma

Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy

HNSCC: tumour antigens and their targeting by immunotherapy

Postoperative recurrence in locally advanced rectal cancer: how does neoadjuvant treatment affect recurrence pattern?

Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge—December 1st–2nd, 2021

The tumour microenvironment, treatment resistance and recurrence in glioblastoma

Infectious morbidity in pediatric patients receiving neoadjuvant chemotherapy for sarcoma

Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs

Does immunotherapy reduce the recurrence rate in nasal polyposis?

Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC

Radiotherapy for patients with locally advanced esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy

Imaging of tumour response to immunotherapy

Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma

Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy

HNSCC: tumour antigens and their targeting by immunotherapy

Postoperative recurrence in locally advanced rectal cancer: how does neoadjuvant treatment affect recurrence pattern?

Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge—December 1st–2nd, 2021

The tumour microenvironment, treatment resistance and recurrence in glioblastoma

Infectious morbidity in pediatric patients receiving neoadjuvant chemotherapy for sarcoma

Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs

Does immunotherapy reduce the recurrence rate in nasal polyposis?

Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC

Radiotherapy for patients with locally advanced esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy combined with chemotherapy

Imaging of tumour response to immunotherapy

Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma

Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy

HNSCC: tumour antigens and their targeting by immunotherapy

Postoperative recurrence in locally advanced rectal cancer: how does neoadjuvant treatment affect recurrence pattern?

Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge—December 1st–2nd, 2021

The tumour microenvironment, treatment resistance and recurrence in glioblastoma

Infectious morbidity in pediatric patients receiving neoadjuvant chemotherapy for sarcoma

Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs

Does immunotherapy reduce the recurrence rate in nasal polyposis?

Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC

Related objects

Reset password